SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech
Synopsis
In return, SciSparc shall issue to Xylo an amount of ordinary shares of the company.
SciSparc Ltd. (SPRC) on Wednesday said that its unit NeuroThera Labs Inc. signed a binding term sheet to acquire a treasury of patents, trademarks and intellectual property rights for innovative endoscopic systems and medical cameras from Xylo Technologies Ltd.
Shares of the company jumped 28% in the pre-market session at the time of writing.
The company said it is also acquiring intellectual property rights to the MUSE system, a single-use, innovative endoscopic device designed for a minimally invasive procedure to treat gastroesophageal reflux disease. In return, SciSparc shall issue to Xylo an amount of ordinary shares of the company.
Get updates to this developing story directly on Stocktwits.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.